RO — Roche Holding AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Roche Holding AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	61,466	58,323	62,801	63,281	58,716
Cost of Revenue
Gross Profit	44,089	42,423	43,453	44,651	43,090
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	43,935	39,794	44,666	45,875	43,555
Operating Profit	17,531	18,529	18,135	17,406	15,161
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	16,614	17,965	17,398	16,327	14,079
Provision for Income Taxes
Net Income After Taxes	14,108	15,068	14,935	13,531	12,358
Minority Interest
Net Income Before Extraordinary Items
Net Income	13,497	14,295	13,930	12,421	11,498
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	13,495	14,294	13,929	12,420	11,498
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	18.3	17	16.6	17.9	18
Dividends per Share